Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry

European Journal of Clinical Pharmacology

Volumn 50, Issue 6, 1996, Pages 449-456

  Hunyady, B ^a,b   Juricskay, I ^a   Nagy, L ^a   Garamszegi, M ^a   Vincze, A ^a   Mozsik G ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Famotidine; Hyperacidity; Intragastric pH metry; Multicategory analysis; Pattern recognition

Indexed keywords

FAMOTIDINE; PENTAGASTRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DUODENUM INJURY; DUODENUM ULCER; ENDOSCOPY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; STATISTICS; STOMACH INJURY; STOMACH PH; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANTI-ULCER AGENTS; DISCRIMINANT ANALYSIS; DRUG EVALUATION; FAMOTIDINE; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTRIC MUCOSA; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0029773389     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050139     Document Type: Article

References (36)

1. Gitlin N, McCullough AJ, Smith JL, Mantell G, Berman R (1987) A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease. Gastroenterology 92:48-53
2. Dobrilla G, de Pretis G, Fontana G, Majolo P, Marenco G, Menardo G (1988) Famotidine (F) in single morning (SM) v single noctural (SN) dose (D) in the treatment of duodenal ulcer (DU). [abstract]. Gut 29:A1441-A1442
3. Bianchi Porro G, Parente F, Sangaletti O (1990) Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing. Gut 31:397-400
4. Celle G, Savarino V, Mela GS, et al (1988) Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. Scand J Gastroenterol 23:385-390
5. Reynolds JR, Walt RP, Hardcastle JD, Clark AG, Smart HL, Langman MJ (1986) 24-hour intragastric pH : continuous monitoring or nasogastric aspiration? Digestion 33:219-224
6. Andersen J, Naesdal J, Ström M (1988) Identical 24-hour gastric pH profiles when using intragastric antimony or glass electrodes or aspirated gastric juice. Scand J Gastroenterol 23: 375-379
7. Savarino V, Mela GS, Zentilin P, et al (1989) Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. Scand J Gastroenterol 24:434-439
8. Chiverton SG, Burget DW, Hunt RH (1989) Validation of pH dataloggers for pharmacologic studies. Scand J Gastroenterol 24:975-981
9. Rohmel J, Merki HS, Wilder-Smith CH, Walt RP (1990) Analysis and statistical evaluation of continuous pH recordings. Dig Dis 8[Suppl 1]:87-96
10. Mela GS, Savarino V, Vigneri S (1992) Optimizing the information obtained from continuous 24-hour gastric pH monitoring. Am J Gastroenterol 87:961-966
11. Emde C (1990) Graphical display and statistical evaluation of data gained by long-term ambulatory intragastric pH monitoring. Dig Dis 8[Suppl 1]:82-86
12. Mela GS, Savarino V, Sumberaz A et al (1990) Continuous acidity monitoring in the study of gastric antisecretory drugs: pH or antilog transformation of pH. mean or median? Am J Gastroenterol 85:1105-1108
13. Mela GS, Savarino V, Caputo E, Sumberaz A, Bonifacino G, Zentilin P (1990) 24-hour gastric pH-metry analysis: influence of arbitrarily predefined time intervals on the reliability of acidity indexes. Am J Gastroenterol 85:381-384
14. Armstrong D, Emde C, Blum AL (1989) Twenty-four-hour intragastric pH-metry studies: easy to do but difficult to analyse. Eur J Gastroenterol Hepatol 1:167-174
15. Armstrong D, Emde C, Roehmel J, Blum AL (1990) Continuous long-term gastric pH-metry: further suggestions for optimizing data analysis - reply, [letter]. Eur J Gastroenterol Hepatol 2:320-323
16. Emde C, Garner A, Blum AL (1987) Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut 28:1177-1188
17. Bumm R, Blum AL, Bauerfeind P, Emde C (1987) Lessons from prolonged gastric pH monitoring. Aliment Pharmacol Ther 1[Suppl 1]:518S-526S
18. Pounder RE, Lanzon-Miller S, Smith JT, et al (1990) Royal Free Hospital protocol for 24-hour acidity and plasma gastrin concentration. Dig Dis 8[Suppl 1]:10-17
19. Juricskay I, Veress GE (1985) PRIMA: A new pattern recognition method. Analytica Chimica Acta 171:61-76
20. Tóth K, Mezey B, Juricskay I, Jávor T (1990) Pattern recognition in evaluation of haemorheological and haemodynamic measurements in the cardiological diaenostics. Acta Med Hung 47:31-42
21. Horváth I, Juricskay I, Mezey B, Vincze Á, Mózsik Gy (1993) Effect of cold pressor test in healthy and hyperacid subjects. J Physiol Paris 87:375-378
22. Hunyady B, Vincze Á, Nagy L, et al (1994) Prospective, controlled clinical study of a Hungarian Al-Mg-containing antacid using intragastric pH-metry. Exp Clin Gastroenterol 4:21-27
23. Mela GS, Savarino V, Moretti M, Bonifacino G, Sumberaz A, Zentilin P (1989) Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. Scand J Gastroenterol 24:683-687
24. Dammann HG, Müller P, Simon B (1983) 24 hour intragastric acidity and single night-time dose of three H2-blockers. [letter]. Lancet 5:1078
25. Bauerfeind P, Cilluffo T, Emde C, et al (1987) Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage. Digestion 37:217-222
26. Savarino V, Mela GS, Zentilin P, et al (1989) Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. Digestion 42:1-6
27. Savarino V, Mela GS, Zenitilin P, Sumberaz A, Cutela P, Celle G (1991) Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring. Digestion 48:141-148
28. Savarino V, Mela GS, Zentilin P, Cutela P, Mele MR, Celle G (1993) Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg. and ranitidine 300 mg. J Clin Pharmacol 33:70-74
29. Lanzon-Miller S, Pounder RE, Mclsaac RL, Wood JR (1990) The timing of the evening meal affects the pattern of 24-hour intragastric acidity. Aliment Pharmacol Ther 4: 547-553
30. Cilluffo T, Armstrong D, Castiglione F et al (1990) Reproducibility of ambulatory gastric pH recordings in the corpus and antrum. Effect of food, time, and electrode position. Scand J Gastroenterol 25:1076-1083
31. Hunyady B, Vincze Á, Pakodi F, Nagy L, Mózsik Gy (1993) Alimentary and circadian changes of intragastric acidity and serum gastrin concentration in hyperacid patients. Exp Clin Gastroenterol 3:236-237
32. Margalith D, Duroux P, Bauerfeind P, et al (1991) Famotidine should be taken with supper: the effect of drug-meal interactions on gastric acidity and plasma famotidine levels. Eur J Gastroenterol Hepatol 3:405-412
33. Burget DW, Chiverton SG, Hum RH (1990) Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 99:345-351
34. Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH (1987) Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 28: 1120-1127
35. Hunyady B, Juricskay I, Pakodi F, Vincze A, Nagy L, Mózsik Gy (1994) A new statistical method for clinical evaluation of the intragastric pH-metry. [abstract]. Gut 35[Suppl 4]:A206
36. Hunyady B, Juricskay I, Pakodi F, Horváth Cs, Mózsik Gy (1996) Diagonstic interpretation of the 24-hour intragastric pH-metry using a pattern recognition method (PRIMA ). Aliment Pharmacol Ther (in press)